Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome

doi:10.4330/wjc.v17.i11.109287

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

(50)

(44)

(0)

(13)

(1)

(1000)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Cardiol. Nov 26, 2025; 17(11): 109287
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.109287

Full Size Figure Download Figure

Figure 1 Kaplan-Meier curves of reaching the device-oriented composite endpoint at 30 months in the observation group and the control group. DoCE: Device-oriented composite endpoint.

Citation: Li J, Li XR, Kong MW, Zhang J. Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome. World J Cardiol 2025; 17(11): 109287
URL: https://www.wjgnet.com/1949-8462/full/v17/i11/109287.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i11.109287

Li J, Li XR, Kong MW, Zhang J. Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome. World J Cardiol 2025; 17(11): 109287 [PMID: 41356584 DOI: 10.4330/wjc.v17.i11.109287]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.